期刊文献+

透明质酸及其相关蛋白与大鼠肝纤维化的关系 被引量:5

Relationship between levels of hyaluronan and hyaluronan-associated proteins and liver fibrosis of rats
下载PDF
导出
摘要 目的:探讨血清透明质酸(HA)及其相关蛋白(SHAP-HA)水平与肝纤维化间的关系.方法:建立实验性肝纤维化动物模型,检测血清HA、SHAP-HA、谷-丙转氨酶(ALT)、谷-草转氨酶(AST)、白蛋白(ALB),观察大鼠肝组织病理变化.结果:随着肝纤维化程度的加重,血清HA、SHAP-HA表达量均增加,与ALT、AST呈正相关,差异具有统计学意义.结论:实验性肝纤维化过程中HA、SHAP-HA表达水平不仅与肝组织的炎症坏死程度有关,而且与纤维化过程关系密切,HA、SHAP-HA可作为肝纤维化评估指标之一. Objective: To investigate the relationship between fibrosis pathology and the levels of hyaluronan (HA) and hya- luronan-associated proteins (SHAP-HA) in serum. Methods: Wistar rats were used to establish the experimental model. The levels of serum HA, SHAP-HA, AST, ALT and ALE, and liver homogenate hydroproline were detected. Results: The HA and SHAP-HA levels of serum were significantly increased compared with normal serum. Positive correlations was found among HA, SHAP-HA, ALT and AST with fibrosis progress. Conclusion: Serum HA and SHAP-HA may be useful as an fibrosis marker, the levels of which may be related more closely in the development of experiment liver fibrosis than in the inflammatory process.
作者 吴吉文 王玮
出处 《解剖学杂志》 CAS CSCD 北大核心 2010年第4期439-442,F0003,共5页 Chinese Journal of Anatomy
基金 人事部留学回国人员科技活动项目(国人厅发[2005]129号)
关键词 肝纤维化 透明质酸 血清 大鼠 liver fibrosis hyaluronan serum rat
  • 相关文献

参考文献9

  • 1Murphy F,Arthur M,Iredale J.Developing strategies for liver fibrosis treatment[J].Exp Opin Invest Drugs,2002,11(11):1575-1585.
  • 2刘平,高云华.肝纤维化动物模型的建立[J].世界华人消化杂志,2002,10(6):693-695. 被引量:34
  • 3中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14010
  • 4Housset C,Guechot J.Hepatic fibrosis:physiopathology and biological diagnosis[J].Pathol Biol (Paris),1999,47(3):886-894.
  • 5Kobayashi H,Horikoshi K,Yamataka A,et al.Hyaluronic acid:a specific prognostic indicator of hepatic damage in biliary atresia[J].J Pediat Surg,1999,34(5):1791-1794.
  • 6Zhao M,Yoneda M,Kimata K,et al.Evidence for the covalent binding of SHAP,heavy chains of inter alpha trypsin inhibitor,to hyaluronan[J].J Biol Chem,1995,270(6):26657-26663.
  • 7Yingsung W,Zhuo L,Ishiguro N,et al.Molecular heterogeneity of the SHAP-hyaluronan complex:Isolation and characterization of the complex in synovial fluid from patients with rheumatoid arthritis[J].J Biol Chem,2003,278(8):32710-32718.
  • 8Kida D,Yoneda M,Miyaura S,et al.The SHAP-HA complex in sera from patients with rheumatoid arthritis and osteoarthritis[J].J Rheumatol,1999,26(3):1230-1238.
  • 9Zhuo L,Kanamori A,Kannagi R,et al.SHAP potentiates the CD44-mediated leukocyte adhesion to hyaluronan substrate[J].J Biol Chem,2006,281(29):203-214.

二级参考文献7

共引文献14039

同被引文献32

  • 1丙型肝炎防治指南[J].临床肝胆病杂志,2004,20(4):197-203. 被引量:735
  • 2伍晓春,陆豫.虎杖的药理作用及临床应用研究进展[J].中医药信息,2005,22(2):22-25. 被引量:80
  • 3肝纤维化中西医结合诊疗指南[J].中西医结合肝病杂志,2006,16(5):316-320. 被引量:168
  • 4邱春嫦,劳小斌.电化学发光免疫法定量检测乙肝病毒的临床应用[J].中国热带医学,2005,5(4):678-679. 被引量:8
  • 5徐叔云,卞如濂,陈修.药理实验方法学[M].3版.北京:人民卫生出版社,2005:1042-1043,1053.
  • 6Wang JH,Choi MK,Shin JW,et al. Antifibrotic effects of Ar temisia capilaris and Artemisia iwayomogi in a carbon tetra- chloride-induced chronic hepatic fibrosis animal model [J]. Journal of Ethnopharmacology, 2012,140( 1 ) : 179.
  • 7Povero D, Busletta C, Novo. et al. Liver fibrosis:a dynamic and potentially reversible process [J ]. Histol Histopathol, 2010,25(8) : 1075.
  • 8钟家异.研究电化学发光定量检测乙肝血清标志物的相关性[J].医药前沿.2012(2):150-151.
  • 9Meziri M,Bouzitoune R,Remita N,et al.Hepatitis fibrosis charac-terization by a multiparametric study[J].J Acoust Soc Am,2013,133(5):3541.
  • 10Hsu CW,Liang KH,Huang SF,et al.Development of a non-invasivefibrosis test for chronic hepatitis B patients and comparison with otherunpatented scores[J].BMC Res Notes,2013,6(1):212.

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部